Investigating the Effect of Intravenous and Oral Tranexamic Acid on Blood Loss After Primary Hip and Knee Arthroplasty (TRAC-24)
Single Centre Randomised Controlled Trial to Assess the Effect of the Addition of Twenty-four Hours of Oral Tranexamic Acid Post-operatively to a Single Intra-operative Intravenous Dose of Tranexamic Acid on Calculated Blood Loss Following Primary Hip and Knee Arthroplasty.
Sponsor: Belfast Health and Social Care Trust
A PHASE4 clinical study on Primary Total Hip Arthroplasty and Primary Total Knee Arthroplasty, this trial is completed. The trial is conducted by Belfast Health and Social Care Trust and has accumulated 6 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
May 2022 — Jul 2024 [monthly]
Completed PHASE4
Status: Unknown Status → Completed
-
Jan 2021 — May 2022 [monthly]
Unknown Status PHASE4
-
Oct 2020 — Jan 2021 [monthly]
Unknown Status PHASE4
Status: Active Not Recruiting → Unknown Status
▶ Show 1 earlier version
-
Nov 2018 — Oct 2020 [monthly]
Active Not Recruiting PHASE4
First recorded
Jul 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Belfast Health and Social Care Trust
For direct contact, visit the study record on ClinicalTrials.gov .